Kidswell Bio

Kidswell Bio EBIT per Share

The EBIT per Share of Kidswell Bio (4584.T) as of Oct 18, 2026 is -7.07 JPY. In the previous year, EBIT per Share was 2.33 JPY — a change of -403.96% (lower).

EBIT per Share

-7.07JPY

YoY

-403.96%

Last updated:

EBIT per Share of Kidswell Bio is 2026 -7.07 JPY. EBIT per Share of Kidswell Bio was 2025 2.33 JPY. It decreases by -403.96% lower compared to the previous year.

The Kidswell Bio EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2022
-20.57 JPY
Jan 1, 2023
-16.60 JPY
Jan 1, 2024
-33.92 JPY
Jan 1, 2025
2.33 JPY
Jan 1, 2026
-7.07 JPY
Jan 1, 2027 (e)
24.05 JPY
Jan 1, 2028 (e)
36.44 JPY
Jan 1, 2029 (e)
40.16 JPY
The Kidswell Bio EBIT per Share history
YEAREBIT per ShareYoY
est40.16JPY+10.23%
est36.44JPY+51.47%
est24.05JPY-440.28%
-7.07JPY-403.96%
2.33JPY-106.86%
-33.92JPY+104.38%
-16.60JPY-19.32%
-20.57JPY-33.98%
-31.16JPY-87.61%
-251.52JPY+763.65%
-29.12JPY-37.41%
-46.53JPY-28.03%
-64.65JPY+299.95%
-16.17JPY-0.45%
-16.24JPY-72.75%
-59.58JPY+4.82%
-56.84JPY-13.77%
-65.92JPY-3.49%
-68.30JPY+43.39%
-47.63JPY-53.04%
-101.43JPY+84.02%
-55.12JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Kidswell Bio Stock analysis

What does Kidswell Bio do? Kidswell Bio Corp, based in Chuo-Ku, Tokyo, operates in the Health Care sector with a focus on Biotechnology. The company develops biopharmaceutical products, including biosimilars for cancer, renal diseases, and eye conditions, as well as innovative therapies such as anti-RAMP2 antibodies and regenerative medicine using stem cells for pediatric heart diseases and congenital disorders. Listed on 30 November 2012, it employs 41 full-time staff. Kidswell Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kidswell Bio stock

EBIT per Share of Kidswell Bio is -7.07 JPY in 2026.

EBIT per Share of Kidswell Bio changed from 2.33 JPY to -7.07 JPY, representing a -403.96% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Kidswell Bio since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Kidswell Bio

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Kidswell Bio